Regeneron Pharmaceuticals
REGN
REGN
718 hedge funds and large institutions have $30.4B invested in Regeneron Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 116 funds opening new positions, 308 increasing their positions, 189 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.01% less ownership
Funds ownership: 68.96% → 68.95% (-0.01%)
27% less funds holding in top 10
Funds holding in top 10: 15 → 11 (-4)
36% less call options, than puts
Call options by funds: $509M | Put options by funds: $791M
Holders
718
Holding in Top 10
11
Calls
$509M
Puts
$791M
Top Buyers
| 1 | +$455M | |
| 2 | +$426M | |
| 3 | +$190M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$95.8M |
| 5 |
State Street
Boston,
Massachusetts
|
+$79M |
Top Sellers
| 1 | -$380M | |
| 2 | -$366M | |
| 3 | -$312M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$208M |
| 5 |
HM
HealthCor Management
New York
|
-$165M |